Log in
RegisterPK sample time points [Regulatives / Guidelines]
Dear All,
As per Guidelines for Bioavailability and Bioequivalence Studies issued by CDSCO-India, intervals between sampling time points used to calculate the terminal elimination rate constant should not be longer than the half life of the study drug. Any reason behind this??
Regards,
Naren
As per Guidelines for Bioavailability and Bioequivalence Studies issued by CDSCO-India, intervals between sampling time points used to calculate the terminal elimination rate constant should not be longer than the half life of the study drug. Any reason behind this??
Regards,
Naren
Complete thread:
- PK sample time pointsNaren 2016-12-02 12:29
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- PK sample time points javier 2016-12-02 13:11
- PK sample time points Yura 2016-12-03 09:49
- PK sample time points javier 2016-12-02 13:11
Ing. Helmut Schütz